Designation granted by FDA recognizes the potential of plixorafenib, a novel, investigational paradox breaker and BRAF inhibitor, to provide substantial improvement over available therapies First ...
Description: Full review with mic and anc samples Affiliate Links When you make a purchase through the Affiliate Links here, ...
If you're struggling to decide on what to pick up during the Steam Spring Sale 2026 - got you covered. Here's a bunch of ...
Hemab Therapeutics, a late stage clinical biotechnology company developing novel prophylactic therapeutics for serious, underserved coagulation disorders, today announced that the U.S. Food and Drug ...
Jaime Tugayev is the News Editor for DualShockers with over a decade of experience, and a much longer love for fantasy, shooters and strategy games. If you like the anxiety of holding the line as ...
With the holiday freebies behind it, the Epic Games Store has restarted its weekly giveaways. Up first is a popular tower defense title. The Epic Games Store just concluded its massive holiday ...
Bloons TD 6 Free On Epic Games Store, Styx: Shards of Darkness And Styx: Master of Shadows Next Week
Craft your perfect defense from a combination of powerful Monkey Towers and awesome Heroes, then pop every last invading Bloon! Over a decade of tower defense pedigree and regular massive updates ...
After a couple of weeks of free games being given away daily for the holidays, the Epic Games Store has returned to its usual cadence to start the new year, with another game being made free for the ...
Starting today, January 8th, and lasting until 11am ET on January 15th, Bloons TD 6 is free to download and keep for good on the Epic Games Store. Developed by Ninja Kiwi, Bloons TD 6 is widely ...
Current NCAA eligibility rules will remain in place for the rest of this academic year as well as the 2026-27 academic year. Kirby Lee / Imagn Images A possible change in college eligibility rules to ...
Breakthrough therapy designation (BTD) is an expedited regulatory pathway designed to accelerate the development of novel therapies that potentially provide substantial clinical benefits, particularly ...
Zongertinib has been granted FDA breakthrough therapy designation for first-line treatment of HER2-mutant NSCLC, expediting its development and review. The Beamion-LUNG 1 trial showed a 71% objective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results